Načítá se...
iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions
Terminal maturation of invariant NKT (iNKT) cells from stage 2 (CD44(+)NK1.1(–)) to stage 3 (CD44(+)NK1.1(+)) is accompanied by a functional acquisition of a predominant IFN-γ–producing (iNKT-1) phenotype; however, some cells develop into IL-17–producing iNKT (iNKT-17) cells. iNKT-17 cells are rare...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Clinical Investigation
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973110/ https://ncbi.nlm.nih.gov/pubmed/24614103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69780 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|